<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2025.1524500</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Sex-specific impact of B cell-derived IL-10 on tuberculosis resistance</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hertz</surname>
<given-names>David</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2892427/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Marwitz</surname>
<given-names>Sebastian</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/820567/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eggers</surname>
<given-names>Lars</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>von Borstel</surname>
<given-names>Linda</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Harikumar Parvathy</surname>
<given-names>Gishnu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Behrends</surname>
<given-names>Jochen</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1076280/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jonigk</surname>
<given-names>Danny D.</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Manz</surname>
<given-names>Rudolf A.</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/342666/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Goldmann</surname>
<given-names>Torsten</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/64607/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Schneider</surname>
<given-names>Bianca E.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/214188/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Host Determinants in Lung Infections, Research Center Borstel, Leibniz Lung Center</institution>, <addr-line>Borstel</addr-line>, <country>Germany</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Core Facility Histology, Research Center Borstel, Leibniz Lung Center</institution>, <addr-line>Borstel</addr-line>, <country>Germany</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL)</institution>, <addr-line>Gro&#xdf;hansdorf</addr-line>, <country>Germany</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Core Facility Fluorescence Cytometry, Research Center Borstel, Leibniz Lung Center</institution>, <addr-line>Borstel</addr-line>, <country>Germany</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Institute of Pathology, University Hospital RWTH Aachen</institution>, <addr-line>Aachen</addr-line>, <country>Germany</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Biomedical Research In Endstage And Obstructive Lung Disease (BREATH), Member of the German Center for Lung Research (DZL)</institution>, <addr-line>Hannover</addr-line>, <country>Germany</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Institute for Systemic Inflammation Research, University of L&#xfc;beck</institution>, <addr-line>L&#xfc;beck</addr-line>, <country>Germany</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Selvakumar Subbian, Rutgers, The State University of New Jersey, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Vianney Ortiz-Navarrete, Center for Research and Advanced Studies, National Polytechnic Institute of Mexico (CINVESTAV), Mexico</p>
<p>Ranjeet Kumar, Rutgers, The State University of New Jersey, United States</p>
<p>Alok Choudhary, Rutgers, The State University of New Jersey, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Bianca E. Schneider, <email xlink:href="mailto:bschneider@fz-borstel.de">bschneider@fz-borstel.de</email>
</p>
</fn>
<fn fn-type="other" id="fn003">
<p>&#x2020;ORCID: Danny D. Jonigk, <uri xlink:href="https://orcid.org/0000-0002-5251-2281">orcid.org/0000-0002-5251-2281</uri>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>07</day>
<month>04</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1524500</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>11</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>03</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Hertz, Marwitz, Eggers, von Borstel, Harikumar Parvathy, Behrends, Jonigk, Manz, Goldmann and Schneider</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Hertz, Marwitz, Eggers, von Borstel, Harikumar Parvathy, Behrends, Jonigk, Manz, Goldmann and Schneider</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>Due to the historical dogma that host defense against intracellular pathogens is primarily mediated by cell-mediated immunity, B cells have long been considered unimportant in providing protection against <italic>Mycobacterium tuberculosis</italic> (Mtb) and remained understudied for decades. However, emerging evidence highlights the multifaceted role of B cells in tuberculosis (TB) immunity. B cells accumulate at the site of infection in both animal models and human TB patients, suggesting a potential link to protective immunity. Still, the diverse roles of B cells in TB immunity are still being unraveled. In addition to producing antibodies, B cells secrete a wide range of cytokines that can influence the local immune response. In this study, we focused on the relevance of interleukin 10 (IL-10)-secreting B cells in the long-term control of the <italic>Mtb</italic> Beijing strain HN878.</p>
</sec>
<sec>
<title>Methods</title>
<p>B cell-specific IL-10 expression was assessed in IL-10 transcriptional reporter (Vert-X) mice following <italic>Mtb</italic> infection. To investigate the role of B cell-derived IL-10 in TB immunity, both male and female mice with a targeted knockout of IL-10 in B cells (IL-10<sup>flox</sup>/CD19<sup>cre</sup>) were infected with <italic>Mtb</italic> HN878. Disease progression, control of bacterial replication, and immunological changes were monitored throughout the course of infection.</p>
</sec>
<sec>
<title>Results</title>
<p>B cells contribute to IL-10 production in the <italic>Mtb</italic>-infected lung in both sexes, with CD138<sup>+</sup> plasma cells serving as the primary source of B cell-derived IL-10. Mice lacking B cell-derived IL-10 exhibited increased resistance to aerosol <italic>Mtb</italic> infection, demonstrated by a delayed onset of clinical symptoms and prolonged survival. Notably, this effect was significantly more pronounced in males compared to females, and was associated with male-specific immune alterations.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Our research highlights a previously unrecognized sex-specific regulatory role of B cell-derived IL-10 during <italic>Mtb</italic> infection.</p>
</sec>

</abstract>
<kwd-group>
<kwd>tuberculosis</kwd>
<kwd>HN878</kwd>
<kwd>mouse model</kwd>
<kwd>B cell-derived IL-10</kwd>
<kwd>sex differences</kwd>
</kwd-group>
<counts>
<fig-count count="4"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="52"/>
<page-count count="14"/>
<word-count count="7372"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Microbial Immunology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Tuberculosis (TB) is the most prevalent bacterial infectious disease in humans with approximately 1.5 million deaths each year (<xref ref-type="bibr" rid="B1">1</xref>). Gender- and sex-related factors lead to significant differences in prevalence between men and women (<xref ref-type="bibr" rid="B2">2</xref>&#x2013;<xref ref-type="bibr" rid="B5">5</xref>), which is reflected by a male-to-female ratio for worldwide case notifications of 1.8 (<xref ref-type="bibr" rid="B1">1</xref>). In a mouse model of TB - using either the reference <italic>Mtb</italic> strain H37Rv or the more virulent clinical isolate HN878 of the Beijing lineage - we previously found that males experienced a more rapid course of disease and succumbed to infection earlier than females, recapitulating the observed sex bias in human TB (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). Interestingly, higher male susceptibility to <italic>Mtb</italic> infection was associated with smaller B cell follicles in the lungs in comparison to <italic>Mtb</italic> infected females. B cell follicles are linked with immune protection in TB in mice, non-human primates, and humans (<xref ref-type="bibr" rid="B8">8</xref>&#x2013;<xref ref-type="bibr" rid="B12">12</xref>). Still, the underlying mechanisms and the functional role of B cells in TB remain poorly defined. A study by Swanson et&#xa0;al. recently showed that antigen-specific B cells direct T follicular-like helper cells into lymphoid follicles to mediate <italic>Mtb</italic> control (<xref ref-type="bibr" rid="B13">13</xref>). However, the role of important B cell effector mechanisms such as antibody and cytokine production have yet to be elucidated.</p>
<p>Earlier studies have shown that the absence of B cells leads to heightened pulmonary inflammation and increased bacterial loads (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>), indicating that B cells play a protective, anti-inflammatory role in TB. B cells can suppress inflammation and modulate cellular immune responses by producing the anti-inflammatory cytokine interleukin-10 (IL-10). These so-called B10 cells are a sub-class of regulatory B-cells (Breg cells) and play a vital role in maintaining immune equilibrium by mitigating inflammation and averting autoimmune reactions (<xref ref-type="bibr" rid="B16">16</xref>). Although IL-10 has beneficial effects in limiting tissue damage, its overproduction or dysregulated expression can favor <italic>Mtb</italic> persistence and chronic infection by limiting host-protective immune responses (<xref ref-type="bibr" rid="B17">17</xref>). As such, T cell-derived IL-10 was shown to contribute to IL-10-induced susceptibility to TB (<xref ref-type="bibr" rid="B18">18</xref>). However, the role of B cell-derived IL-10 is still not fully understood and requires further investigation. B10 cells were detected in <italic>Mtb</italic> infected mouse lungs, especially during the chronic phase (<xref ref-type="bibr" rid="B18">18</xref>) and in blood of patients with active TB (<xref ref-type="bibr" rid="B19">19</xref>). <italic>In vitro</italic> stimulation assays confirmed that B cells produce IL-10 in response to mycobacterial antigen (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>). Mannose-capped lipoarabinomannan (ManLAM), a major surface lipoglycan component from <italic>Mtb</italic>, was shown to be a very potent inducer of B10 cells <italic>in vitro</italic> and <italic>in vivo</italic> (<xref ref-type="bibr" rid="B19">19</xref>). Notably, these B10 cells inhibited Th1 polarization, and promoted Th2 polarization, suggesting that ManLAM-induced B10 cells negatively regulate anti-<italic>Mtb</italic> immunity. In order to gain a clearer understanding of the precise involvement of B10 cells in TB, we opted to delve deeper into their functionality <italic>in vivo</italic>. To do so, we infected male and female mice harboring a targeted knockout of IL-10 in B cells (IL-10<sup>flox</sup>/CD19<sup>cre</sup>) with <italic>Mtb</italic> HN878 and monitored disease progression, control of bacterial replication and immunological changes over the course of infection. Absence of B cell-derived IL-10 significantly improved survival of HN878 infected mice compared to their B cell IL-10 competent littermates, but of note, the survival advantage was higher in males compared to females. Improved male survival was associated with reduced bacterial loads and profound alterations in the lung immune environment. Collectively, our findings provide compelling evidence that B cell-derived IL-10 plays a far more critical role in regulating the male immune response to <italic>Mtb</italic> infection compared to females. These findings highlight the critical need for further investigations into the mechanisms underlying sex-based differences in TB immunity.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Mice</title>
<p>C57BL/6j mice were bred under specific-pathogen-free (SPF) conditions at the Research Center Borstel. IL-10 reporter mice (Vert-X) which express enhanced green fluorescent protein (eGFP) under the control of the IL-10 promoter (<xref ref-type="bibr" rid="B22">22</xref>) were bred under SPF conditions at the animal facility of the University of L&#xfc;beck. IL-10 flox/flox mice (B6.129P2(C)-Il10tm1Roer/MbogJ), with loxP sites that flank exon 1 of IL-10, were bred under SPF conditions with CD19-Cre mice (B6.129P2(C)-Cd19tm1(cre)Cgn/J) at the animal facility of the University of L&#xfc;beck, resulting in the generation of mice with B cell-specific inactivation of IL-10 (B cell IL-10 KO), and IL-10 competent littermate controls (<xref ref-type="bibr" rid="B23">23</xref>). For infection experiments, male and female mice aged between 11-20 weeks were maintained under barrier conditions in the BSL 3 facility at the Research Center Borstel in individually ventilated cages. Animal experiments were in accordance with the German Animal Protection Law and approved by the Ethics Committee for Animal Experiments of the Ministry of Agriculture, Rural Areas, European Affairs and Consumer Protection of the State of Schleswig-Holstein.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Mtb infection and determination of bacterial load</title>
<p>
<italic>Mtb</italic> HN878 was grown in Middlebrook 7H9 broth (BD Biosciences, Franklin Lakes, USA) supplemented with 10% v/v OADC (Oleic acid, Albumin, Dextrose, Catalase) enrichment medium (BD Biosciences, Franklin Lakes, USA) to logarithmic growth phase (OD<sub>600</sub> 0.2 - 0.4) and aliquots were frozen at -80&#xb0;C. Viable cell number in thawed aliquots were determined by plating serial dilutions onto Middlebrook 7H11 agar plates supplemented with 10% v/v OADC followed by incubation at 37&#xb0;C for 3-4 weeks. For infection of experimental animals, <italic>Mtb</italic> stocks were thawed and diluted in sterile distilled water to a concentration providing an uptake of approximately 50 viable bacilli per lung. The bacterial suspension was used directly after preparation, with infection carried out via the respiratory route by using an aerosol chamber (Glas-Col, Terre-Haute, USA) as described previously (<xref ref-type="bibr" rid="B6">6</xref>). The inoculum size was quantified 24 h after infection in the lungs and bacterial loads in lung and spleen were evaluated at different time points after aerosol infection by determining colony forming units (CFU). Organs were removed aseptically, weighed, and homogenized in 0.05% v/v Tween 20 in PBS containing a proteinase inhibitor cocktail (Roche, Basel, Switzerland) prepared according to the manufacturer&#x2019;s instructions for subsequent quantification of cytokines (see below). Tenfold serial dilutions of organ homogenates in sterile water/1% v/v Tween 80/1% w/v albumin were plated onto Middlebrook 7H11 agar plates supplemented with 10% v/v OADC and incubated at 37&#xb0;C for 3&#x2013;4 weeks.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Clinical score</title>
<p>Clinical score was used to indicate severity of disease progression (<xref ref-type="bibr" rid="B7">7</xref>). Animals were scored in terms of general behavior, activity, feeding habits, and weight gain or loss. Each of the criteria is assigned score points from 1 to 5 with 1 being the best and 5 the worst. The mean of the score points represents the overall score for an animal. Animals with severe symptoms (reaching a clinical score of &#x2265;3.5) were euthanized to avoid unnecessary suffering, and the time point was recorded as the end point of survival for that individual mouse.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Flow cytometry</title>
<p>Mice were sacrificed and perfused intracardially with sterile PBS before organ harvest. Lungs were digested in 100 &#xb5;g/ml DNase I (Roche, Basel, Switzerland) and 50 &#xb5;g/ml Liberase TL (Roche, Basel, Switzerland) in RPMI for 60 minutes and passed through a 100 &#xb5;m pore size cell strainer to obtain a single cell suspension. Single-cell suspensions were blocked with anti-CD16/CD32 (clone 93, Biolegend, Fell, Germany) and sera (rat, rabbit, mouse (PAN Biotech, Aidenbach, Germany) and hamster (abcam, Cambridge, UK)) for 30 min at 4&#xb0;C. Subsequently, cells were washed and incubated for 30 min at 4&#xb0;C with the following antibodies: BV510 anti-CD45 (clone 30-F11); BV421 or PerCP-Cy5.5 anti-CD138 (clone 281-2); APC anti-GL7 (clone GL7) and BV421 anti-CD8a (clone 53-6.7) from BioLegend, Fell, Germany and PE-Cy7 anti-B220 (clone RA3-6B2) and APC-H7 anti-CD4 (clone GK1.5) from BD Biosciences, Franklin Lakes, USA. After washing, cells were resuspended in FACS buffer (3% fetal calf serum heat-inactivated, 0.1% NaN<sub>3</sub>, 2 mM EDTA) and analyzed on a MACSQuant Analyzer 10 (Miltenyi Biotec B.V. &amp; Co. KG, Bergisch Gladbach, Germany). Imaging of IL-10 producing B cells were performed on a BD FACSDiscover&#x2122; S8 Cell Sorter with BD CellView<sup>&#x2122;</sup> Image Technology and BD SpectralFX<sup>&#x2122;</sup> Technology (BD Biosciences, Franklin Lakes, USA). Data were analyzed with the FCSExpress software (DeNovo&#x2122; Software, Pasadena, USA) and the Cytolution software (Cytolytics GmbH, T&#xfc;bingen, Germany).</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Multiplex cytokine assay</title>
<p>The concentrations of cytokines and chemokines in lung homogenates were determined by LEGENDplex&#x2122; (Mouse Inflammation panel (IL-23, IL-1&#x3b1;, IFN-&#x3b3;, TNF-&#x3b1;, CCL2, IL-12p70, IL-1&#x3b2;, IL-10, IL-6, IL-27, IL-17A, IFN-&#x3b2;, GM-CSF) and Mouse Proinflammatory Chemokine Panel (CXCL1, CCL5, CCL20, CCL11, CCL17, CCL2, CXCL9, CXCL10, CCL3, CCL4, CXCL13, CXCL5, CCL22) respectively, BioLegend, Fell, Germany) according to the manufacturer&#x2019;s protocol.</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Mtb specific antibody quantification</title>
<p>High-binding 96-well ELISA plates (SARSTEDT AG &amp; Co. KG, N&#xfc;mbrecht, Germany) were coated with 20 &#xb5;g/ml HN878 whole-cell lysate (BEI resources, Manassas, United States) for 1 h at 37&#xb0;C and blocked with 3% bovine serum albumin (BSA) in Tris-buffered saline (TBS) overnight at 4&#xb0;C. After washing 3 times with TBS&#x2009;+&#x2009;0.1% Tween 20 (TBST), lung homogenates (1:10 dilution in TBS/1% BSA) or TBS as control were added and incubated for 1 h at 37&#xb0;C. After an additional washing step, alkaline phosphatase (AP)-conjugated goat anti-mouse IgG, IgM and IgA (SouthernBiotech, Birmingham, USA) were added at 1:1000 dilution in TBS/1% BSA and incubated for 1&#x2009;h at 37&#xb0;C. After washing four times with TBST, p-Nitrophenylphosphate was added. The reaction was incubated at RT for 20 minutes, then stopped with 1 N NaOH. Absorbance was measured at 405 nm.</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Histology</title>
<p>Superior lung lobes from infected mice were fixed with 4% w/v paraformaldehyde for 24 h, embedded in paraffin, and sectioned (4 &#x3bc;m). Sections were stained with hematoxylin and eosin (H&amp;E; Merck) or carbolfuchsin (Merck) followed by decolorization with acid-alcohol to visualize mycobacteria in the lungs. Slides were imaged with a PhenoImager&#x2122; HT instrument (Akoya Biosciences, Marlborough, USA). The quantitative analysis of inflammatory area was performed by determining the total lung area and the inflammatory area in H&amp;E-stained sections using the software QuPath (<ext-link ext-link-type="uri" xlink:href="https://qupath.github.io/">https://qupath.github.io/</ext-link>) (<xref ref-type="bibr" rid="B24">24</xref>).</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>Multiplex-immunofluorescence staining</title>
<p>Formalin-fixed, paraffin-embedded (FFPE) samples of mouse lung tissues were deparaffinized by immersion into xylene (2x 10 min) and rehydrated by graded series of ethanol (2x 2 min 100%, 2 min 96%, 2 min 90%, 2 min 80%, 2 min 70%, 2 min distilled water). Rehydrated samples were transferred to 1x TBST (50 mM Tris, pH 7.6, 0.05% Tween-20) and subsequently forwarded to mIF staining (<xref ref-type="bibr" rid="B25">25</xref>). The Opal 3-Plex Anti-Rb Manual Detection Kit (NEL840001KT, Akoya Biosciences, Marlborough, USA) was used with additional fluorophores as indicated in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S1</bold>
</xref>. Overall, mIF staining consisted of several, subsequent cycles of IF staining targeting one antigen per time: Before antigen detection, endogenous peroxidases were blocked once by incubation for 10 min at RT in 3% H<sub>2</sub>O<sub>2</sub> followed by washing with 1x TBST. One IF cycle consisted of 10 min protein blocking using antibody diluent (Akoya Biosciences, Marlborough, USA) followed by 3x 2 min washing with 1x TBST. All tissue underwent heat-induced epitope retrieval (HIER) with citric acid buffer pH6 (Akoya Biosciences, Marlborough, USA) prior to protein blocking and incubation with primary antibody. Primary antibodies were diluted using antibody diluent (Akoya Biosciences, Marlborough, USA) and incubated for 45 min at RT followed by 3x 3 min washing with 1x TBST. Primary antibodies were detected by incubation for 10 min with HRP-Polymer (Akoya Biosciences, Marlborough, USA) and subsequent TBST washing for 3x 3 min. Signals were visualized by OPAL-TSA reaction for 10 min at RT and stopped by washing 3x for 3 min with 1x TBST. HIER for 1 min at 1000 W and 10 min at 100 W was used to remove primary antibodies and HRP polymer before entering the next staining cycle. Finally, nuclei were stained using spectral DAPI (Akoya Biosciences, Marlborough, USA) and slides were mounted with cover slips using ProLong Gold (Invitrogen, Carlsbad, USA). Please see <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S1</bold>
</xref> for a detailed pipetting protocol for the mIF panel. The panel was developed using positive control tissues and antigen stability was tested for each antibody by increasing rounds of AR using citric acid buffer pH6 to determine optimal positioning within each mIF panel. Single-plex stains for each target of the multiplex panel from the respective cycle were conducted and their results qualitatively compared to multiplex results for concordance of overall staining pattern, intensity and frequency of detected cells.</p>
</sec>
<sec id="s2_9">
<label>2.9</label>
<title>mIF imaging and digital image analysis</title>
<p>Whole-slide imaging (WSI) was performed using a PhenoImager HT multi-spectral slide scanner (Akoya Biosciences, Marlborough, USA) at 20x magnification (0.5 &#xb5;m/pixel) with exposure times held constant for all analyzed samples (DAPI: 1.39ms, Opal 480: 10 ms, Opal 520: 20 ms, Opal 570: 55 ms, Opal 780: 15 ms). Phenochart software 1.1.0 (Akoya Biosciences, Marlborough, USA) was used to select regions of interest for generation of image analyses algorithm as well as batch analyses across all tissues. For this, an analysis algorithm was built using InForm software 2.6.0 (Akoya Biosciences, Marlborough, USA) with representative regions across different samples. The image analysis algorithm consisted of several steps including spectral unmixing based on proprietary spectral libraries of designated fluorochromes as supplied by Akoya Biosciences, Marlborough, USA, pixel-based tissue segmentation, cell segmentation and cell classification. Representative regions from several different WSIs were imported into InForm software, spectrally unmixed and forwarded to user-guided, machine-learning tissue segmentation based on manual annotation for areas consisting either of empty glass/no tissue, B cell enriched tissue and tissue without B cell enrichment. Tissue segmentation accuracy was tested on randomly selected WSIs and re-trained on areas where initial tissue segmentation failed to correctly identify designated areas. Once the tissue segmentation reached satisfactory level, individual cells were segmented based on their DAPI signal and accessory information from antibody staining. A cell classification algorithm was trained to identify each antigen in a binary approach (antigen positive vs negative). For analysis of WSIs, the complete tissue was deconstructed into boxes and subjected to batch analyses. All images were individually reviewed and areas containing imaging artifacts (dust, fibers, tissues folds, out-of-focus) as well as pleura with excess autofluorescence removed. Resulting cell segmentation files of 828 images from 18 WSIs were merged and consolidated into a single data file using R package phenoptr reports 0.3.3 (<xref ref-type="bibr" rid="B26">26</xref>). Phenoptr reports was further used to determine the cell density (cells/mm<sup>2</sup>) for selected combinations of detected antigens across the complete tissue of each animal. The slides were analyzed in a blinded manner.</p>
</sec>
<sec id="s2_10">
<label>2.10</label>
<title>NanoString analysis</title>
<p>Superior lung lobes from infected mice were fixed with 4% w/v paraformaldehyde for 24 h and embedded in paraffin. RNA was extracted with RNeasy FFPE Kit (Qiagen, Germantown, USA) from tissue sections, dissolved in nuclease-free water and RNA integrity analyzed using a 2100 Bioanalyzer (RNA 6000 Nano Kit, Agilent Technologies, Waldbronn, Germany). Samples with DV200 values &gt;30% were included for gene expression analysis. The NanoString nCounter (NanoString Technologies, Inc., Seattle, USA) platform was used to assess the effects of B cell derived IL-10 on changes in immune gene expression. Briefly, RNA (n = 3/group) was analyzed using the nCounter Host response panel (catalog # 115000486), which includes 773 immune-related genes and 12 internal reference genes for data normalization. Assays were performed using a nCounter Prep Station 5s (NanoString Technologies, Inc., Seattle, USA) according to the manufacturer&#x2019;s instructions, and the proceeded cartridge was sent for digital analysis using the nCounter<sup>&#xae;</sup> Sprint Profiler system (performed at the Institute of Pathology, Hannover Medical School, Hannover, Germany). Briefly, RNA is directly tagged with a capture probe and a reporter probe specific to the genes of interest. After hybridization, samples were washed and the purified target-probe complexes were aligned and immobilized onto the nCounter cartridge. The transcripts were counted via detection of the fluorescent barcodes within the reporter probe. Raw gene expression data were analyzed using NanoString&#x2019;s software nSolver v4.0 with the Advanced Analysis Module v2.0.134 and ROSALIND<sup>&#xae;</sup> (<ext-link ext-link-type="uri" xlink:href="https://nanostring.rosalind.bio">https://nanostring.rosalind.bio</ext-link>).</p>
</sec>
<sec id="s2_11">
<label>2.11</label>
<title>Statistical analysis</title>
<p>All data were analyzed using GraphPad Prism 10 (GraphPad Software, La Jolla, USA) or Excel 2016 (Microsoft Corporation, Redmond, USA). Statistical tests are indicated in the individual Figure legends. Correlation was determined by calculating Pearson&#x2019;s coefficient using a two-tailed analysis. A correlation was taken into account as of r&#x2265; 0.60 (defined as strong correlation). Principal Component Analysis (PCA) was performed in BioVinci version 3.0.9 (BioTuring Inc., San Diego, USA) &#x2013; a machine learning aided analysis platform for biological datasets.</p>
</sec>
<sec id="s2_12">
<label>2.12</label>
<title>Data availability</title>
<p>All data generated or analyzed during this study are included in this published article [and its <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Information Files</bold>
</xref>].</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>B cells contribute to IL-10 production after Mtb infection in males and females</title>
<p>It has previously been shown that B cells are a source of IL-10 during <italic>Mtb</italic> HN878 infection in female mice (<xref ref-type="bibr" rid="B18">18</xref>). Given that sex-based differences in the frequencies of IL-10-producing B cells have been reported in mouse models of arthritis (<xref ref-type="bibr" rid="B27">27</xref>), our goal was to assess B cell-specific IL-10 expression following <italic>Mtb</italic> infection in a sex-specific manner. To define IL-10 production <italic>in vivo</italic>, we utilized male and female IL-10 transcriptional reporter (Vert-X) mice, which express enhanced green fluorescent protein (eGFP) under the control of the IL-10 promoter (<xref ref-type="bibr" rid="B22">22</xref>). They are bred on a C57BL/6 background and exhibited increased male susceptibility in the late stage of <italic>Mtb</italic> HN878 infection (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S1</bold>
</xref>), consistent with previous findings reported by our group for C57BL/6 mice (<xref ref-type="bibr" rid="B7">7</xref>).</p>
<p>Vert-X mice were infected via the aerosol route with <italic>Mtb</italic> HN878, and at the indicated time points, single-cell suspensions of lung tissues were prepared and analyzed for GFP expression (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>; gating strategy in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S2</bold>
</xref>). Consistent with previous studies (<xref ref-type="bibr" rid="B18">18</xref>), T cells were the main producers of IL-10, and furthermore, we did not determine differences between the sexes (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). IL-10 expressing B cells, defined as GFP<sup>+</sup>CD138<sup>-</sup>B220<sup>+</sup> B cells and GFP<sup>+</sup>CD138<sup>+</sup>B220<sup>var</sup> plasma B cells (where B220<sup>var</sup> refers to variable B220 expression, as plasma cells can downregulate B220), were detected in the lungs of both sexes at all-time points investigated. Even though the proportion of these cells within the overall population of IL-10 producers remained constant (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>), the total number of IL-10-producing B cells increased over time (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>). While UMAP analysis revealed a consistent increase in the proportion of GL7<sup>+</sup> germinal center B cells, CD138<sup>+</sup> plasma cells (PCs) remained a relatively small population throughout the infection (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1E, F</bold>
</xref>). However, PCs were by far the most significant producers of IL-10 at all-time points analyzed (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1G&#x2013;K</bold>
</xref>). This aligns with established literature that identifies PCs as the major source of B cell-derived IL-10 <italic>in vivo</italic> across various disease models, including autoimmune, malignant and infectious conditions (<xref ref-type="bibr" rid="B28">28</xref>). Statistical analysis revealed that there were no significant differences in the proportion of IL-10<sup>+</sup> PCs and the expression of IL-10 on a per cell basis in males compared to females after <italic>Mtb</italic> infection (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1I, J</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>B cells produce IL-10 after Mtb infection in males and females. <bold>(A)</bold> Experimental setup. To define IL-10 production <italic>in vivo</italic>, female and male IL-10 reporter mice (Vert-X) were infected via aerosol with <italic>Mtb</italic> HN878 and at the indicated time points, single-cell suspensions of lung tissues were analyzed for GFP expression by flow cytometry. <bold>(B)</bold> shows frequencies of IL10<sup>+</sup> T cells (as combined CD4<sup>+</sup>CD45<sup>+</sup> plus CD8<sup>+</sup>CD45<sup>+</sup> cells). <bold>(C)</bold> shows frequencies and <bold>(D)</bold> total B cells numbers (defined as CD138<sup>+</sup>B220<sup>var</sup> + CD138<sup>-</sup>B220<sup>+</sup>) among IL10<sup>+</sup>CD45<sup>+</sup> cells. <bold>(E)</bold> shows UMAP projection of plasma cells (CD138<sup>+</sup>B220<sup>var</sup>), germinal center B cells (GL7<sup>+</sup>CD138<sup>-</sup>B220<sup>+</sup>) and other B cell subtypes (CD138<sup>-</sup>B220<sup>+</sup>) and <bold>(G)</bold> of IL-10 producing B cell subtypes in male and female lungs at day 84. <bold>(F, H)</bold> show frequencies of the respective cell subsets at different time points post <italic>Mtb</italic> infection. <bold>(I)</bold> shows the frequency of CD138<sup>+</sup>B220<sup>var</sup> cells among IL-10<sup>+</sup> B cells and <bold>(J)</bold> median fluorescence intensity (MFI) of IL-10 in IL-10 producing CD138<sup>+</sup>B220<sup>var</sup> cells. <bold>(K)</bold> Representative image of a IL-10<sup>+</sup>CD138<sup>+</sup>B220<sup>var</sup> cell of a female Vert-X mouse from day 42 p.i. <bold>(B, C, D, I, J)</bold> Each data point represents one mouse. Data were combined from 2 independent experiments; n = 5-10. Statistical analysis was performed by 2way ANOVA followed by Tukey&#x2019;s multiple comparisons test. <bold>(E, G)</bold> Data were generated from 4 female and 5 male mice on day 84 p.i. from 1 representative out of 2 experiments. <bold>(F, H)</bold> Data are represented as the mean percentage of B cell subtypes to total B cells from 2 independent experiments; n=5-10.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1524500-g001.tif"/>
</fig>
<p>Overall, B cells contribute to IL-10 production in the <italic>Mtb</italic> infected lung in both sexes, with CD138<sup>+</sup> PCs representing the primary source of B cell-derived IL-10.</p>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>IL-10 deficiency in B cells renders mice more resistant to Mtb HN878 infection</title>
<p>To determine the actual role of B cell-derived IL-10 during <italic>Mtb</italic> infection we evaluated disease progression in mice that were deficient in IL-10 expression specifically in B cells (<italic>Cd19-cre<sup>+/-</sup>Il10<sup>fl/fl</sup>;</italic> B cell IL-10 KO) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). B cell IL-10 KO mice were more resistant to the <italic>Mtb</italic> infection than their littermates as reflected by reduced body weight loss and a prolonged survival (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S3</bold>
</xref>, <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>). Intriguingly, segregation of survival data by sex revealed that the survival benefit in the absence of B cell-derived IL-10 was more pronounced in males compared to females (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2C, D</bold>
</xref>). Together, these data clearly argue against a protective role for B cell-derived IL-10 but instead suggest it increases susceptibility to TB, particularly in males.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Ablation of B cell derived IL-10 increases resistance of mice to Mtb infection. <bold>(A)</bold> Experimental setup. Female and male B cell IL-10 KO mice and their B cell IL-10 competent littermates were infected via aerosol with <italic>Mtb</italic> HN878 and analyzed at the indicated time points. <bold>(B)</bold> Survival of female (n=9) and male (n=9) B cell IL-10 KO mice and their female (n=5) and male (n=7) B cell IL-10 competent littermates. Survival stratified by sex is shown in <bold>(C)</bold> for females and <bold>(D)</bold> for males. CFU of the lung <bold>(E)</bold> and spleen <bold>(F)</bold> at day 82 p.i. and day 103 p.i. G) Representative micrographs of acid-fast stained lung sections from moribund female and male littermates and B cell IL-10 KO mice. Bar = 20 &#xb5;m. Spider chart of cytokines <bold>(H)</bold> and chemokines <bold>(I)</bold> measured in lung homogenates from female and male littermates and B cell IL-10 KO mice at day 82 p.i. Concentrations of cytokines/chemokines are shown as pg/ml. IFN-&#x3b3; <bold>(J)</bold> and IL-27 <bold>(K)</bold> in lung homogenates from female (orange) and male (blue) littermates and B cell IL-10 KO mice at day 82 p.i. <bold>(L)</bold> Correlation of IFN-&#x3b3; and IL-27 levels as pooled data for littermates and B cell IL-10 KO mice for both sexes. <bold>(B&#x2013;D)</bold>&#xa0;Each data point represents one mouse from one experiment. Statistical analysis was performed by log rank test. <bold>(E, F)</bold> Each data point represents one mouse from one representative experiment out of two (n = 4-7). Statistical analysis was performed by Student&#x2019;s t-test. <bold>(H&#x2013;L)</bold> Each data point represents one mouse from one representative experiment out of two (n = 3-6). Statistical analysis was performed by 2way ANOVA followed by Tukey&#x2019;s multiple comparisons test. Correlation was calculated using Pearson correlation. LOD, limit of detection.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1524500-g002.tif"/>
</fig>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Ablation of B cell IL-10 improves control of Mtb and alters the cytokine profile in male lungs</title>
<p>We next investigated whether the improved survival observed in mice lacking B cell-derived IL-10 resulted from a better ability to control bacterial loads after HN878 infection. Day 82 analysis of lung tissue revealed no significant difference in bacterial burden between groups. However, by day 103, male B cell IL-10 KO mice exhibited a significantly lower lung bacterial load compared to male littermates (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2E</bold>
</xref>), who displayed initial signs of disease around this time (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S3C</bold>
</xref>). In support of our CFU data, analysis of acid-fast bacteria in the lungs of moribund animals revealed that male littermates frequently harbored clusters of mycobacteria, while the KO mice more commonly contained single bacteria (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2G</bold>
</xref>). B cell IL-10 deficiency did not affect bacterial burden in the spleen (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2F</bold>
</xref>), suggesting distinct roles for B cell-derived IL-10 in the lung and spleen during <italic>Mtb</italic> infection.</p>
<p>To examine the immunological environment in the lungs that accompanied improved bacterial control in the absence of B cell IL-10, we quantified the levels of inflammatory cytokines and chemokines known to play a role in <italic>Mtb</italic> infection. While absence of B cell IL-10 did not lead to overall changes in the levels of cyto- or chemokines in female lungs (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2H, I</bold>
</xref>), it had profound effects on certain cytokines in male lungs (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2H</bold>
</xref>). Specifically, we observed significant changes in IFN-&#x3b3; and IL-27 levels, with differences being evident not only between littermate and B cell IL-10 KO mice, but also between males and females (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2J, K</bold>
</xref>). Interestingly, male littermates displayed significantly lower levels of IFN-&#x3b3; compared to females (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2J</bold>
</xref>), which increased significantly in the absence of B cell-derived IL-10. In contrast to IFN-&#x3b3;, IL-27 levels were significantly higher in male littermates compared to females (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2K</bold>
</xref>). Notably, the absence of B cell IL-10 led to a significant decrease in IL-27 levels specifically in male mice. This reduction brought their IL-27 levels down to a level comparable to that observed in female mice. This difference in how B cell IL-10 regulates IFN-&#x3b3; and IL-27 between the sexes is further supported by correlation analysis (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2L</bold>
</xref>). A strong negative correlation between IL-27 and IFN-&#x3b3; levels was observed in male mice, while this negative correlation was absent in female mice, indicating a possible different regulatory pathway for these cytokines in female mice compared to male mice.</p>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Histopathological changes in lung tissue from Mtb infected B cell IL-10 KO mice</title>
<p>IL-27, like IL-10, is an important anti-inflammatory cytokine that has a dual role in TB. On the one hand, IL-27 limits protective immunity to <italic>Mtb</italic> but on the other hand it prevents from excessive inflammation and immunopathology (<xref ref-type="bibr" rid="B29">29</xref>). Thus, we next evaluated the granulomatous response in absence of B cell-derived IL-10, which led to a significant reduction in IL-27 levels in males (see <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2K</bold>
</xref>). To this end, H&amp;E-stained lung sections from B cell IL-10 KO mice and littermates were examined 82 days after HN878 infection (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). No significant difference in cellular infiltration was observed in the lungs of female B cell IL-10 KO mice compared to their female littermates. In contrast, male B cell IL-10 KO mice showed a trend towards greater cellular infiltration compared to their male littermates, which, although not statistically significant, is still noteworthy (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). In fact, the absence of B cell-derived IL-10 in males led to levels of cellular infiltration in the lungs comparable to those observed in females. This suggests that B cell-derived IL-10 plays a specific role in down-regulating the inflammatory response within the lungs of male mice during <italic>Mtb</italic> infection. The results from the histological examination align remarkably well with the cytokine analysis, which is further supported by the observed correlations (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3C, D</bold>
</xref>). In males, a strong positive correlation exists between the area of inflammation and IFN-&#x3b3; levels (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>), while conversely, a negative correlation was observed between inflammation and IL-27 levels (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>). Notably, these correlations were absent in females, indicating a potentially distinct inflammatory pathway in females that is not influenced by B cell-derived IL-10.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Ablation of B cell IL-10 increases cellular infiltration into the male lung. Female and male B cell IL-10 KO mice and B cell IL-10 competent littermates were infected via aerosol with <italic>Mtb</italic> HN878. Lungs were collected at day 82 and PFA-fixed, paraffin embedded tissue sections were stained with H&amp;E. <bold>(A)</bold> Representative micrographs from one female and male mouse lung per genotype are shown. Bar = 1 mm. <bold>(B)</bold> Quantitative analysis of the area of lung inflammation shown in <bold>(A)</bold> segregated by sex and correlations with the levels of IFN-&#x3b3; <bold>(C)</bold> and IL-27 <bold>(D)</bold>. <bold>(E)</bold>&#xa0;Representative micrographs from lungs of one female and male mouse per group stained with antibodies to detect neutrophils (NE<sup>+</sup>) and macrophages (CD68<sup>+</sup>); Bar = 100 &#xb5;m. <bold>(F, G)</bold> Quantitative analysis of immune cells as shown in <bold>(E)</bold>. H) PCA of integrated datasets (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S2</bold>
</xref>). Datasets were standardized using the default algorithm in BioVinci and integrated into a PCA plot. <bold>(B&#x2013;D, F&#x2013;H)</bold> Each data point represents one mouse from one representative experiment out of two; n = 3-6. Statistical analysis was performed by 2way ANOVA followed by Tukey&#x2019;s multiple comparisons test (B F, G). Correlation was calculated using Pearson correlation <bold>(C, D)</bold>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1524500-g003.tif"/>
</fig>
<p>The sex-specific differences in cellular infiltration and the potential role of B cell-derived IL-10 in males prompted a more detailed examination of immune cell populations within the infected lung using mIF to identify CD19<sup>+</sup> B cells, CD3<sup>+</sup> T cells, CD68<sup>+</sup> macrophages, and neutrophil elastase positive (NE<sup>+</sup>) neutrophils (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;4A</bold>
</xref>). Consistent with our previous findings (<xref ref-type="bibr" rid="B7">7</xref>), the total area and density of CD19<sup>+</sup> B cells within the lesions were lower in male compared to female littermates, although not statistically significant (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures S4B, C</bold>
</xref>). Interestingly, B cell IL-10 deficiency did not significantly affect B cell area or density in either sex. Likewise, our analysis of CD3<sup>+</sup> T cells revealed no major difference between littermates and B cell IL-10 KO mice, or &#x2013; unlike CD19<sup>+</sup> B cells - between the sexes (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;4D</bold>
</xref>). In contrast, B cell IL-10 deficiency significantly impacted macrophages and neutrophils in males (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3E</bold>
</xref>). Although the overall abundance was low, male littermates exhibited a significantly higher density of NE<sup>+</sup> neutrophils within their lesions compared to females, and B cell IL-10 deficiency led to a reduction in neutrophils specifically in males, but not in females (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3F</bold>
</xref>). Conversely, male B cell IL-10 KO mice had a marked increase in CD68<sup>+</sup> macrophages compared to littermates, while macrophage density in females remained similar regardless of B cell IL-10 status (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3G</bold>
</xref>).</p>
<p>In order to understand the combined influence of the measured parameters described, we employed Principal Component Analysis (PCA) on our comprehensive dataset of day 82 post infection (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S2</bold>
</xref>). The first three principal components (PCs) captured a significant portion (61%) of the total variance within the dataset (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3H</bold>
</xref>). The PCA plot revealed a distinct separation between male littermates and all other groups. Interestingly, male B cell IL-10 KO clustered closer to the combined group of female littermates and female B cell IL-10 KO mice. This suggests a sex-based difference in the overall immune response to <italic>Mtb</italic> infection. Moreover, the closer proximity of male B cell IL-10 KO mice to females aligns with their improved survival compared to male littermates.</p>
<p>Overall, these data suggest that the absence of B cell-derived IL-10 has a more pronounced effect on the immune response in males, making them more susceptible to <italic>Mtb</italic> in its presence.</p>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Gene expression analysis reveals B cell IL-10 dependent regulation of immune response gene transcripts in a sex-specific manner</title>
<p>To better understand the molecular basis of the observed sex differences in susceptibility and lung inflammation following <italic>Mtb</italic> infection in mice that lack B cell-derived IL-10, we employed the nCounter platform to analyze immune-related gene expression profiles in the lungs that we had analyzed by mIF before (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S3</bold>
</xref>). Sex-wise gene expression analysis revealed a striking disparity: Only few genes were differentially expressed in female B cell IL-10 KO mice compared to female controls (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). In stark contrast, male B cell IL-10 KO mice displayed significant changes, with 114 genes being differentially regulated, most of which were downregulated (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). Quantitative analysis of pathway scores revealed a striking sex difference in response to B cell IL-10 deficiency. Pathway scores in males showed greater variation compared to their female counterparts, where scores remained relatively unchanged by B cell IL-10 depletion (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4C, D</bold>
</xref>). Notably, the JAK-STAT pathway, known to play a central role in mediating the effects of IL-10, exhibited the most significant downregulation in male B cell IL-10 KO mice (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4E</bold>
</xref>). Additionally, pathways related to B cell receptor (BCR) and IL-2 signaling were also downregulated in males, while the host defense peptides pathway showed a contrasting increase (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4F&#x2013;H</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Ablation of B cell derived IL-10 leads to significant changes in immune response gene transcripts in a sex-specific manner. B cell IL-10 KO mice and their B cell IL-10 competent littermates were infected via aerosol with HN878. Lungs were collected at day 82 and PFA-fixed, paraffin embedded tissue sections were used to extract RNA. Gene expression was analyzed with the nCounter Host Response Panel by Nanostring technology. <bold>(A,&#xa0;B)</bold>&#xa0;Volcano plots of log2 fold change versus -log10 p-value of the differential gene expression between female <bold>(A)</bold> and male <bold>(B)</bold> B cell IL-10 KO mice and their B cell IL-10 competent littermates. Horizontal dot line represents p-value &lt;0.05. Significantly upregulated genes in B cell IL-10 KO mice are represented as blue dots, significantly downregulated genes are red; n = 3/group. <bold>(C, D)</bold> Selected trend plots of pathway signatures for female and male littermates and B cell IL-10 KO mice. <bold>(E&#x2013;H)</bold> Most significantly different pathway signatures are depicted for female and male B cell IL-10 KO mice and their B cell IL-10 competent littermates. Each data point represents one mouse from one experiment; n = 3/group. Mycobacteria-specific IgG <bold>(I)</bold>, IgM <bold>(J)</bold> and IgA <bold>(K)</bold> titers were measured in lung homogenates at day 82 p.i. Each data point represents one mouse from one representative experiment out of two (n = 3-6). Statistical analysis was performed by Student&#x2019;s t-Test.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1524500-g004.tif"/>
</fig>
<p>Given the downregulation of BCR in male B cell IL-10 KO mice, we aimed to assess the impact on <italic>Mtb</italic>-specific B cell responses. To do this, we measured immunoglobulins in lung homogenates that recognized antigens in an <italic>Mtb</italic> whole-cell lysate (WCL). Although we observed no differences in the titer of anti-mycobacterial IgG and IgM antibodies between sexes or between littermates and B cell IL-10 KO (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4I, J</bold>
</xref>), anti-mycobacterial IgA levels were reduced in B cell IL-10 KO mice, with the reduction reaching significance only in male mice (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4K</bold>
</xref>). This finding is consistent with previous reports indicating that IL-10 promotes the generation of plasma cells and enhances IgA production (<xref ref-type="bibr" rid="B30">30</xref>&#x2013;<xref ref-type="bibr" rid="B33">33</xref>).</p>
<p>Collectively, these findings provide compelling evidence for our hypothesis that B cell-derived IL-10 plays a far more critical role in regulating the male immune response during <italic>Mtb</italic> infection compared to females.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>Within the TB granuloma, B cells are organized in granuloma-associated lymphoid tissue and exhibit a highly specific spatial localization, organization, and function (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>). They play a crucial role in orchestrating immune responses at the site of infection and influence the cells in close proximity (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B36">36</xref>). Although there is increasing evidence of an important role for B cells in TB, the exact role of their various effector functions is not fully understood.</p>
<p>IL-10-producing B cells have been identified in <italic>Mtb</italic> infection across mice and humans (<xref ref-type="bibr" rid="B18">18</xref>&#x2013;<xref ref-type="bibr" rid="B21">21</xref>), but their presence and function have not been investigated from a sex-specific perspective. Moreover, earlier studies suggested that B cells participate in <italic>Mtb</italic> control independent of the production of IL-10 (<xref ref-type="bibr" rid="B13">13</xref>) while T cells have been recognized as the major source of IL-10 that promotes TB susceptibility (<xref ref-type="bibr" rid="B18">18</xref>). These earlier studies demonstrated that B cell IL-10 deficient mice could still control <italic>Mtb</italic>. However, Moreira-Teixeira used only female mice and evaluated bacterial growth after 60 days of infection (<xref ref-type="bibr" rid="B18">18</xref>), while Swanson determined bacterial burden 50 and 100 days post infection but did not report on the sex of the mice (<xref ref-type="bibr" rid="B13">13</xref>). In contrast to these studies, we investigated the impact of B cell IL-10 in both male and female mice and monitored their survival in addition to bacterial burden. In line with the previous results, we also did not observe a reduction in bacterial load in the absence of B cell IL-10 in females but in males, and these mice also exhibited significantly improved survival.</p>
<p>Our study reveals a previously unidentified role for B cell-derived IL-10 in regulating immunity during TB. Intriguingly, immunological analysis, including gene expression data using NanoString technology, demonstrated a significantly broader impact of B cell IL-10 on the male immune response compared to females. While female B cell IL-10 KO mice displayed minimal changes in cytokine/chemokine profiles or gene expression, ablation of B cell IL-10 had a profound effect on the immunological environment in the male lung. Notably, it reversed the sex-specific pattern of IFN-&#x3b3; and IL-27 which likely contributes significantly to the higher susceptibility of males to <italic>Mtb</italic> infection. Male control mice exhibited significantly lower IFN-&#x3b3; but higher IL-27 levels compared to females. IFN-&#x3b3; is essential to control TB infection (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B38">38</xref>), whereas IL-27 has been previously shown to have a dual role, acting as a double-edged sword: suppressing protective immunity against TB and bacterial clearance, while simultaneously dampening excessive inflammation (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B40">40</xref>). Studies using mice deficient in WSX-1, a component of the IL-27 receptor, revealed increased activation of CD4<sup>+</sup> T cells and IFN-&#x3b3; production (<xref ref-type="bibr" rid="B40">40</xref>). This enhanced immune response improved macrophage function and reduced bacterial burden. However, this beneficial effect was counterbalanced by a more severe chronic inflammatory state, ultimately accelerating death in WSX-1 KO mice. Supporting the proposed mechanism, the significant decrease in IL-27 levels in male B cell IL-10 KO mice observed in our study coincided with increased IFN-&#x3b3; production, reduced bacterial burden, and enhanced inflammation, mainly due to a rise in CD68<sup>+</sup> macrophages. Importantly, despite the increased inflammation, survival rates in these male B cell IL-10 KO mice were extended compared to their wild-type littermates. Presumably, the inflammation was still regulated to some extent and did not progress to the severe, damaging characteristics typically observed in complete absence of IL-27. These findings strongly suggest that B cell-derived IL-10 plays a critical, previously unrecognized role in determining the sex-specific immune response during TB infection. Moreover, this is the first study to demonstrate the potential regulation of IL-27 by IL-10. Whether the reduction in IL-27 expression in males is a direct consequence of B cell IL-10 deficiency or occurs indirectly via modulation of IFN-&#x3b3; or other pathways warrants further investigation.</p>
<p>Sex disparities in immune responses are well-established, with females generally displaying a stronger humoral and cellular response and a more pro-inflammatory gene expression profile (<xref ref-type="bibr" rid="B41">41</xref>). Previous studies have demonstrated that estrogen can regulate the IFN-&#x3b3; promoter, leading to increased IFN-&#x3b3; production (<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B43">43</xref>). This suggests a potential role for estrogen in driving higher IFN-&#x3b3; production in females during <italic>Mtb</italic> infection. However, a key question remains: why does B cell IL-10 specifically regulate IFN-&#x3b3; expression in males but not females? We did not observe significant differences in the frequency of B10 cells between male and female mice. Hence, sex-specific regulation likely occurs downstream of IL-10 production or at the level of IL-10 receptor expression. Interestingly, Islam et&#xa0;al. (<xref ref-type="bibr" rid="B44">44</xref>) observed increased STAT3 activation in male leukocytes in response to IL-10, which could potentially explain the specific suppression of IFN-&#x3b3; in males through a pathway involving STAT3, known to downregulate IFN-&#x3b3; (<xref ref-type="bibr" rid="B45">45</xref>). Noteworthy, the JAK-STAT signaling pathway was one of the pathways most influenced by B cell IL-10 deficiency in males. However, the precise details of how B cell-derived IL-10 specifically activates STAT3 signaling only in males and how this impacts disease outcome requires further investigation.</p>
<p>While the JAK-STAT signaling pathway was downregulated in B cell IL-10 KO males, the host defense peptide pathway was enhanced. This, along with our histological data showing increased CD68<sup>+</sup> macrophages in the lungs of these B cell IL-10 KO males, suggests a possible shift in the immune response towards a more macrophage-mediated defense mechanism in the absence of B cell-derived IL-10 in males. Tissue-resident B cells were recently shown to play a crucial role in regulating macrophage polarization and function, partly through the production of IL-10 (<xref ref-type="bibr" rid="B46">46</xref>). This aligns with findings from a model of LPS-induced acute lung injury, where B cell-derived IL-10 inhibited macrophage activation and recruitment (<xref ref-type="bibr" rid="B47">47</xref>). However, this has not been shown in the context of <italic>Mtb</italic> infection before, where studies have focused on the negative impact of T cell or macrophage-derived IL-10 on macrophage polarization and function (<xref ref-type="bibr" rid="B48">48</xref>&#x2013;<xref ref-type="bibr" rid="B50">50</xref>).</p>
<p>Our study uncovers a previously unknown sex-specific role for B cell-derived IL-10 in TB immunity. The observation of enhanced STAT3 activation in males compared to females (<xref ref-type="bibr" rid="B44">44</xref>) hints at a potential factor contributing to this sex-specific effect. Other possible reasons for a sex-specific role of B cell-derived IL-10 include differences in B cell positioning, which may be influenced by sex hormones. Testosterone, for example, has been shown to suppress B cell positioning and germinal center formation, contributing to distinct immune regulation patterns in males and females (<xref ref-type="bibr" rid="B51">51</xref>). This is consistent with our previous findings of smaller B cell follicles in males, suggesting that testosterone may influence follicle size and organization, potentially through B cell positioning (<xref ref-type="bibr" rid="B7">7</xref>). As a result of differences in follicle size and positioning, B cells may interact with other immune cells in a sex-specific manner in <italic>Mtb</italic>-infected lungs. The localization and spatial organization of B cells within the granuloma might also explain why T cell-derived IL-10 does not appear to compensate for loss of IL-10 production from B cells. Direct cell contact or proximity between the IL-10-producing cell and the target cell seems to be essential, as shown for the interaction between B cells and neutrophils (<xref ref-type="bibr" rid="B52">52</xref>) or B cells and macrophages (<xref ref-type="bibr" rid="B46">46</xref>). Notably, B cell-derived IL-10 has been shown to play a non-redundant role in immune counter-regulation (<xref ref-type="bibr" rid="B22">22</xref>). This suggests the intriguing possibility that B cell IL-10 serves a distinct, sex-specific regulatory role in TB, potentially driven by differences in the localization of B cell responses between males and females.</p>
<p>In conclusion, our findings highlight a role for B cell IL-10 in regulating sex differences in the immune response observed in TB infection. Understanding these sex-based disparities in B cell distribution and IL-10 regulation could be crucial for developing more targeted and effective TB treatment strategies.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>Normalized linear count datasets are available within the GEO online repository under accession numbers GSE292976 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292976). Additional inquiries on data availability should be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was approved by Ethics Committee for Animal Experiments of the Ministry of Agriculture, Rural Areas, European Affairs and Consumer Protection of the State of Schleswig-Holstein. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>DH: Conceptualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing, Data curation, Formal Analysis, Investigation. SM: Formal Analysis, Writing &#x2013; review &amp; editing, Methodology. LE: Methodology, Writing &#x2013; review &amp; editing, Investigation. LB: Investigation, Methodology, Writing &#x2013; review &amp; editing. GH: Writing &#x2013; review &amp; editing, Data curation, Formal Analysis. JB: Formal Analysis, Writing &#x2013; review &amp; editing, Investigation, Methodology. DJ: Methodology, Writing &#x2013; review &amp; editing. RM: Methodology, Writing &#x2013; review &amp; editing, Resources. TG: Methodology, Resources, Writing &#x2013; review &amp; editing. BS: Resources, Conceptualization, Project administration, Supervision, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the Life Science-Stiftung (FZB 2020.01) and in-house funding from the Research Center Borstel.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We would like to thank Silvia Maass for culturing <italic>Mtb</italic>; Kathleen Kurwahn (ISEF L&#xfc;beck) and the staff of the animal facility at the Research Center Borstel for animal care; Christian Rosero and Jasmin Tiebach for their help with the immunohistochemistry and preparation of the NanoString cartridge and Martina Hein for her help with the flow cytometry experiments. In addition, we would like to express our gratitude to Can Pinar and Marie Kr&#xfc;ger of Cytolytics for their assistance in analyzing our flow cytometry data using the Cytolution software.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2025.1524500/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2025.1524500/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
<supplementary-material xlink:href="Table1.xlsx" id="ST1" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="book">
<person-group person-group-type="author">
<collab>WHO</collab>
</person-group>. <source>Global tuberculosis report 2023</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name> (<year>2023</year>). Licence: CC BY-NC-SA 3.0 IGO. 2023.</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borgdorff</surname> <given-names>MW</given-names>
</name>
<name>
<surname>Nagelkerke</surname> <given-names>NJ</given-names>
</name>
<name>
<surname>Dye</surname> <given-names>C</given-names>
</name>
<name>
<surname>Nunn</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Gender and tuberculosis: a comparison of prevalence surveys with notification data to explore sex differences in case detection</article-title>. <source>Int J tuberculosis Lung disease: Off J Int Union against Tuberculosis Lung Disease</source>. (<year>2000</year>) <volume>4</volume>:<page-range>123&#x2013;32</page-range>.</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hertz</surname> <given-names>D</given-names>
</name>
<name>
<surname>Schneider</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Sex differences in tuberculosis</article-title>. <source>Semin immunopathology</source>. (<year>2019</year>) <volume>41</volume>:<page-range>225&#x2013;37</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00281-018-0725-6</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horton</surname> <given-names>KC</given-names>
</name>
<name>
<surname>MacPherson</surname> <given-names>P</given-names>
</name>
<name>
<surname>Houben</surname> <given-names>RM</given-names>
</name>
<name>
<surname>White</surname> <given-names>RG</given-names>
</name>
<name>
<surname>Corbett</surname> <given-names>EL</given-names>
</name>
</person-group>. <article-title>Sex differences in tuberculosis burden and notifications in low- and middle-income countries: A systematic review and meta-analysis</article-title>. <source>PloS Med</source>. (<year>2016</year>) <volume>13</volume>:<fpage>e1002119</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pmed.1002119</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname> <given-names>M</given-names>
</name>
<name>
<surname>Srikrishna</surname> <given-names>G</given-names>
</name>
<name>
<surname>Klein</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Bishai</surname> <given-names>WR</given-names>
</name>
</person-group>. <article-title>Genetic and hormonal mechanisms underlying sex-specific immune responses in tuberculosis</article-title>. <source>Trends Immunol</source>. (<year>2022</year>) <volume>43</volume>:<page-range>640&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.it.2022.06.004</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dibbern</surname> <given-names>J</given-names>
</name>
<name>
<surname>Eggers</surname> <given-names>L</given-names>
</name>
<name>
<surname>Schneider</surname> <given-names>BE</given-names>
</name>
</person-group>. <article-title>Sex differences in the C57BL/6 model of Mycobacterium tuberculosis infection</article-title>. <source>Sci Rep</source>. (<year>2017</year>) <volume>7</volume>:<fpage>10957</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-017-11438-z</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hertz</surname> <given-names>D</given-names>
</name>
<name>
<surname>Dibbern</surname> <given-names>J</given-names>
</name>
<name>
<surname>Eggers</surname> <given-names>L</given-names>
</name>
<name>
<surname>von Borstel</surname> <given-names>L</given-names>
</name>
<name>
<surname>Schneider</surname> <given-names>BE</given-names>
</name>
</person-group>. <article-title>Increased male susceptibility to Mycobacterium tuberculosis infection is associated with smaller B cell follicles in the lungs</article-title>. <source>Sci Rep</source>. (<year>2020</year>) <volume>10</volume>:<fpage>5142</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-020-61503-3</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khader</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Guglani</surname> <given-names>L</given-names>
</name>
<name>
<surname>Rangel-Moreno</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gopal</surname> <given-names>R</given-names>
</name>
<name>
<surname>Junecko</surname> <given-names>BA</given-names>
</name>
<name>
<surname>Fountain</surname> <given-names>JJ</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung</article-title>. <source>J Immunol</source>. (<year>2011</year>) <volume>187</volume>:<page-range>5402&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1101377</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slight</surname> <given-names>SR</given-names>
</name>
<name>
<surname>Rangel-Moreno</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gopal</surname> <given-names>R</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Fallert Junecko</surname> <given-names>BA</given-names>
</name>
<name>
<surname>Mehra</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>CXCR5(+) T helper cells mediate protective immunity against tuberculosis</article-title>. <source>J Clin Invest</source>. (<year>2013</year>) <volume>123</volume>:<page-range>712&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI65728</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ulrichs</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kosmiadi</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Jorg</surname> <given-names>S</given-names>
</name>
<name>
<surname>Pradl</surname> <given-names>L</given-names>
</name>
<name>
<surname>Titukhina</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mishenko</surname> <given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>Differential organization of the local immune response in patients with active cavitary tuberculosis or with nonprogressive tuberculoma</article-title>. <source>J Infect diseases</source>. (<year>2005</year>) <volume>192</volume>:<fpage>89</fpage>&#x2013;<lpage>97</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1086/430621</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ulrichs</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kosmiadi</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Trusov</surname> <given-names>V</given-names>
</name>
<name>
<surname>Jorg</surname> <given-names>S</given-names>
</name>
<name>
<surname>Pradl</surname> <given-names>L</given-names>
</name>
<name>
<surname>Titukhina</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung</article-title>. <source>J pathology</source>. (<year>2004</year>) <volume>204</volume>:<page-range>217&#x2013;28</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/path.1628</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Linge</surname> <given-names>I</given-names>
</name>
<name>
<surname>Kondratieva</surname> <given-names>E</given-names>
</name>
<name>
<surname>Apt</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Prolonged B-lymphocyte-mediated immune and inflammatory responses to tuberculosis infection in the lungs of TB-resistant mice</article-title>. <source>Int J Mol Sci</source>. (<year>2023</year>) <volume>24</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms24021140</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swanson</surname> <given-names>RV</given-names>
</name>
<name>
<surname>Gupta</surname> <given-names>A</given-names>
</name>
<name>
<surname>Foreman</surname> <given-names>TW</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Choreno-Parra</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Mbandi</surname> <given-names>SK</given-names>
</name>
<etal/>
</person-group>. <article-title>Antigen-specific B cells direct T follicular-like helper cells into lymphoid follicles to mediate Mycobacterium tuberculosis control</article-title>. <source>Nat Immunol</source>. (<year>2023</year>) <volume>24</volume>:<page-range>855&#x2013;68</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41590-023-01476-3</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choreno-Parra</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Bobba</surname> <given-names>S</given-names>
</name>
<name>
<surname>Rangel-Moreno</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ahmed</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mehra</surname> <given-names>S</given-names>
</name>
<name>
<surname>Rosa</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Mycobacterium tuberculosis HN878 infection induces human-like B-cell follicles in mice</article-title>. <source>J Infect diseases</source>. (<year>2020</year>) <volume>221</volume>:<page-range>1636&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/infdis/jiz663</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maglione</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chan</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis</article-title>. <source>J Immunol</source>. (<year>2007</year>) <volume>178</volume>:<page-range>7222&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.178.11.7222</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tedder</surname> <given-names>TF</given-names>
</name>
</person-group>. <article-title>B10 cells: a functionally defined regulatory B cell subset</article-title>. <source>J Immunol</source>. (<year>2015</year>) <volume>194</volume>:<page-range>1395&#x2013;401</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1401329</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Redford</surname> <given-names>PS</given-names>
</name>
<name>
<surname>Murray</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>O&#x2019;Garra</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>The role of IL-10 in immune regulation during M. tuberculosis infection</article-title>. <source>Mucosal Immunol</source>. (<year>2011</year>) <volume>4</volume>:<page-range>261&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/mi.2011.7</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreira-Teixeira</surname> <given-names>L</given-names>
</name>
<name>
<surname>Redford</surname> <given-names>PS</given-names>
</name>
<name>
<surname>Stavropoulos</surname> <given-names>E</given-names>
</name>
<name>
<surname>Ghilardi</surname> <given-names>N</given-names>
</name>
<name>
<surname>Maynard</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Weaver</surname> <given-names>CT</given-names>
</name>
<etal/>
</person-group>. <article-title>T cell-derived IL-10 impairs host resistance to mycobacterium tuberculosis infection</article-title>. <source>J Immunol</source>. (<year>2017</year>) <volume>199</volume>:<page-range>613&#x2013;23</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1601340</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname> <given-names>C</given-names>
</name>
<name>
<surname>Qu</surname> <given-names>ZL</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>XL</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>W</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Mycobacterium tuberculosis mannose-capped lipoarabinomannan induces IL-10-producing B cells and hinders CD4(+)Th1 immunity</article-title>. <source>iScience</source>. (<year>2019</year>) <volume>11</volume>:<fpage>13</fpage>&#x2013;<lpage>30</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.isci.2018.11.039</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>du Plessis</surname> <given-names>WJ</given-names>
</name>
<name>
<surname>Kleynhans</surname> <given-names>L</given-names>
</name>
<name>
<surname>du Plessis</surname> <given-names>N</given-names>
</name>
<name>
<surname>Stanley</surname> <given-names>K</given-names>
</name>
<name>
<surname>Malherbe</surname> <given-names>ST</given-names>
</name>
<name>
<surname>Maasdorp</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>The functional response of B cells to antigenic stimulation: A preliminary report of latent tuberculosis</article-title>. <source>PloS One</source>. (<year>2016</year>) <volume>11</volume>:<elocation-id>e0152710</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0152710</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>du Plessis</surname> <given-names>WJ</given-names>
</name>
<name>
<surname>Walzl</surname> <given-names>G</given-names>
</name>
<name>
<surname>Loxton</surname> <given-names>AG</given-names>
</name>
</person-group>. <article-title>B cells as multi-functional players during Mycobacterium tuberculosis infection and disease</article-title>. <source>Tuberculosis</source>. (<year>2016</year>) <volume>97</volume>:<page-range>118&#x2013;25</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tube.2015.10.007</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Madan</surname> <given-names>R</given-names>
</name>
<name>
<surname>Demircik</surname> <given-names>F</given-names>
</name>
<name>
<surname>Surianarayanan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Allen</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Divanovic</surname> <given-names>S</given-names>
</name>
<name>
<surname>Trompette</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Nonredundant roles for B cell-derived IL-10 in immune counter-regulation</article-title>. <source>J Immunol</source>. (<year>2009</year>) <volume>183</volume>:<page-range>2312&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.0900185</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname> <given-names>L</given-names>
</name>
<name>
<surname>Almeida</surname> <given-names>LN</given-names>
</name>
<name>
<surname>Clauder</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Lindemann</surname> <given-names>T</given-names>
</name>
<name>
<surname>Luther</surname> <given-names>J</given-names>
</name>
<name>
<surname>Link</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Bone marrow plasma cells modulate local myeloid-lineage differentiation via IL-10</article-title>. <source>Front Immunol</source>. (<year>2019</year>) <volume>10</volume>:<elocation-id>1183</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.01183</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bankhead</surname> <given-names>P</given-names>
</name>
<name>
<surname>Loughrey</surname> <given-names>MB</given-names>
</name>
<name>
<surname>Fernandez</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Dombrowski</surname> <given-names>Y</given-names>
</name>
<name>
<surname>McArt</surname> <given-names>DG</given-names>
</name>
<name>
<surname>Dunne</surname> <given-names>PD</given-names>
</name>
<etal/>
</person-group>. <article-title>QuPath: Open source software for digital pathology image analysis</article-title>. <source>Sci Rep</source>. (<year>2017</year>) <volume>7</volume>:<fpage>16878</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-017-17204-5</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoyt</surname> <given-names>CC</given-names>
</name>
</person-group>. <article-title>Multiplex immunofluorescence and multispectral imaging: forming the basis of a clinical test platform for immuno-oncology</article-title>. <source>Front Mol Biosci</source>. (<year>2021</year>) <volume>8</volume>:<elocation-id>674747</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmolb.2021.674747</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname> <given-names>K</given-names>
</name>
</person-group>. <source>Create Reports Using Phenoptics Data. phenoptrReports</source> (<year>2022</year>). Available online at: <uri xlink:href="https://akoyabio.github.io/phenoptrReports/">https://akoyabio.github.io/phenoptrReports/</uri> (May 8, 2024).</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luckey</surname> <given-names>D</given-names>
</name>
<name>
<surname>Medina</surname> <given-names>K</given-names>
</name>
<name>
<surname>Taneja</surname> <given-names>V</given-names>
</name>
</person-group>. <article-title>B cells as effectors and regulators of sex-biased arthritis</article-title>. <source>Autoimmunity</source>. (<year>2012</year>) <volume>45</volume>:<page-range>364&#x2013;76</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3109/08916934.2012.665528</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fillatreau</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Natural regulatory plasma cells</article-title>. <source>Curr Opin Immunol</source>. (<year>2018</year>) <volume>55</volume>:<page-range>62&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.coi.2018.09.012</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ritter</surname> <given-names>K</given-names>
</name>
<name>
<surname>Rousseau</surname> <given-names>J</given-names>
</name>
<name>
<surname>Holscher</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Interleukin-27 in tuberculosis: A sheep in wolf&#x2019;s clothing</article-title>? <source>Front Immunol</source>. (<year>2021</year>) <volume>12</volume>:<elocation-id>810602</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.810602</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arpin</surname> <given-names>C</given-names>
</name>
<name>
<surname>Dechanet</surname> <given-names>J</given-names>
</name>
<name>
<surname>Van Kooten</surname> <given-names>C</given-names>
</name>
<name>
<surname>Merville</surname> <given-names>P</given-names>
</name>
<name>
<surname>Grouard</surname> <given-names>G</given-names>
</name>
<name>
<surname>Briere</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Generation of memory B cells and plasma cells <italic>in vitro</italic>
</article-title>. <source>Science</source>. (<year>1995</year>) <volume>268</volume>:<page-range>720&#x2013;2</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.7537388</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marconi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Plebani</surname> <given-names>A</given-names>
</name>
<name>
<surname>Avanzini</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Maccario</surname> <given-names>R</given-names>
</name>
<name>
<surname>Pistorio</surname> <given-names>A</given-names>
</name>
<name>
<surname>Duse</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-10 and IL-4 co-operate to normalize <italic>in vitro</italic> IgA production in IgA-deficient (IgAD) patients</article-title>. <source>Clin Exp Immunol</source>. (<year>1998</year>) <volume>112</volume>:<page-range>528&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1365-2249.1998.00589.x</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bagheri</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Babaha</surname> <given-names>F</given-names>
</name>
<name>
<surname>Falak</surname> <given-names>R</given-names>
</name>
<name>
<surname>Yazdani</surname> <given-names>R</given-names>
</name>
<name>
<surname>Azizi</surname> <given-names>G</given-names>
</name>
<name>
<surname>Sadri</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-10 induces TGF-beta secretion, TGF-beta receptor II upregulation, and IgA secretion in B cells</article-title>. <source>Eur Cytokine Netw</source>. (<year>2019</year>) <volume>30</volume>:<page-range>107&#x2013;13</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1684/ecn.2019.0434</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Winter</surname> <given-names>H</given-names>
</name>
<name>
<surname>Elewaut</surname> <given-names>D</given-names>
</name>
<name>
<surname>Turovskaya</surname> <given-names>O</given-names>
</name>
<name>
<surname>Huflejt</surname> <given-names>M</given-names>
</name>
<name>
<surname>Shimeld</surname> <given-names>C</given-names>
</name>
<name>
<surname>Hagenbaugh</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Regulation of mucosal immune responses by recombinant interleukin 10 produced by intestinal epithelial cells in mice</article-title>. <source>Gastroenterology</source>. (<year>2002</year>) <volume>122</volume>:<page-range>1829&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1053/gast.2002.33655</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stewart</surname> <given-names>P</given-names>
</name>
<name>
<surname>Patel</surname> <given-names>S</given-names>
</name>
<name>
<surname>Comer</surname> <given-names>A</given-names>
</name>
<name>
<surname>Muneer</surname> <given-names>S</given-names>
</name>
<name>
<surname>Nawaz</surname> <given-names>U</given-names>
</name>
<name>
<surname>Quann</surname> <given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>Role of B cells in mycobacterium tuberculosis infection</article-title>. <source>Vaccines (Basel)</source>. (<year>2023</year>) <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/vaccines11050955</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krause</surname> <given-names>R</given-names>
</name>
<name>
<surname>Ogongo</surname> <given-names>P</given-names>
</name>
<name>
<surname>Tezera</surname> <given-names>L</given-names>
</name>
<name>
<surname>Ahmed</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mbano</surname> <given-names>I</given-names>
</name>
<name>
<surname>Chambers</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>B cell heterogeneity in human tuberculosis highlights compartment-specific phenotype and functional roles</article-title>. <source>Commun Biol</source>. (<year>2024</year>) <volume>7</volume>:<fpage>584</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s42003-024-06282-7</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Linge</surname> <given-names>I</given-names>
</name>
<name>
<surname>Kondratieva</surname> <given-names>T</given-names>
</name>
<name>
<surname>Apt</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>B-cell follicles in tuberculous lung: Active defenders or modest bystanders</article-title>? <source>Immunology</source>. (<year>2023</year>) <volume>169</volume>:<page-range>515&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/imm.v169.4</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooper</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Adams</surname> <given-names>LB</given-names>
</name>
<name>
<surname>Dalton</surname> <given-names>DK</given-names>
</name>
<name>
<surname>Appelberg</surname> <given-names>R</given-names>
</name>
<name>
<surname>Ehlers</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>IFN-gamma and NO in mycobacterial disease: new jobs for old hands</article-title>. <source>Trends Microbiol</source>. (<year>2002</year>) <volume>10</volume>:<page-range>221&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0966-842X(02)02344-2</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooper</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Dalton</surname> <given-names>DK</given-names>
</name>
<name>
<surname>Stewart</surname> <given-names>TA</given-names>
</name>
<name>
<surname>Griffin</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Russell</surname> <given-names>DG</given-names>
</name>
<name>
<surname>Orme</surname> <given-names>IM</given-names>
</name>
</person-group>. <article-title>Disseminated tuberculosis in interferon gamma gene-disrupted mice</article-title>. <source>J Exp Med</source>. (<year>1993</year>) <volume>178</volume>:<page-range>2243&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.178.6.2243</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erdmann</surname> <given-names>H</given-names>
</name>
<name>
<surname>Behrends</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ritter</surname> <given-names>K</given-names>
</name>
<name>
<surname>Holscher</surname> <given-names>A</given-names>
</name>
<name>
<surname>Volz</surname> <given-names>J</given-names>
</name>
<name>
<surname>Rosenkrands</surname> <given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>The increased protection and pathology in Mycobacterium tuberculosis-infected IL-27R-alpha-deficient mice is supported by IL-17A and is associated with the IL-17A-induced expansion of multifunctional T cells</article-title>. <source>Mucosal Immunol</source>. (<year>2018</year>) <volume>11</volume>:<page-range>1168&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41385-018-0026-3</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holscher</surname> <given-names>C</given-names>
</name>
<name>
<surname>Holscher</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ruckerl</surname> <given-names>D</given-names>
</name>
<name>
<surname>Yoshimoto</surname> <given-names>T</given-names>
</name>
<name>
<surname>Yoshida</surname> <given-names>H</given-names>
</name>
<name>
<surname>Mak</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis</article-title>. <source>J Immunol</source>. (<year>2005</year>) <volume>174</volume>:<page-range>3534&#x2013;44</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.174.6.3534</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klein</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Flanagan</surname> <given-names>KL</given-names>
</name>
</person-group>. <article-title>Sex differences in immune responses</article-title>. <source>Nat Rev Immunol</source>. (<year>2016</year>) <volume>16</volume>:<page-range>626&#x2013;38</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri.2016.90</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fox</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Bond</surname> <given-names>BL</given-names>
</name>
<name>
<surname>Parslow</surname> <given-names>TG</given-names>
</name>
</person-group>. <article-title>Estrogen regulates the IFN-gamma promoter</article-title>. <source>J Immunol</source>. (<year>1991</year>) <volume>146</volume>:<page-range>4362&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.146.12.4362</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Su</surname> <given-names>MA</given-names>
</name>
</person-group>. <article-title>An inconvenient variable: sex hormones and their impact on T cell responses</article-title>. <source>J Immunol</source>. (<year>2019</year>) <volume>202</volume>:<page-range>1927&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1801403</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Islam</surname> <given-names>H</given-names>
</name>
<name>
<surname>Jackson</surname> <given-names>GS</given-names>
</name>
<name>
<surname>Yoon</surname> <given-names>JSJ</given-names>
</name>
<name>
<surname>Cabral-Santos</surname> <given-names>C</given-names>
</name>
<name>
<surname>Lira</surname> <given-names>FS</given-names>
</name>
<name>
<surname>Mui</surname> <given-names>AL</given-names>
</name>
<etal/>
</person-group>. <article-title>Sex differences in IL-10&#x2019;s anti-inflammatory function: greater STAT3 activation and stronger inhibition of TNF-alpha production in male blood leukocytes ex vivo</article-title>. <source>Am J Physiol Cell Physiol</source>. (<year>2022</year>) <volume>322</volume>:<page-range>C1095&#x2013;C104</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpcell.00091.2022</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wan</surname> <given-names>CK</given-names>
</name>
<name>
<surname>Andraski</surname> <given-names>AB</given-names>
</name>
<name>
<surname>Spolski</surname> <given-names>R</given-names>
</name>
<name>
<surname>Li</surname> <given-names>P</given-names>
</name>
<name>
<surname>Kazemian</surname> <given-names>M</given-names>
</name>
<name>
<surname>Oh</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Opposing roles of STAT1 and STAT3 in IL-21 function in CD4+ T cells</article-title>. <source>Proc Natl Acad Sci United States America</source>. (<year>2015</year>) <volume>112</volume>:<page-range>9394&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1511711112</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suchanek</surname> <given-names>O</given-names>
</name>
<name>
<surname>Ferdinand</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Tuong</surname> <given-names>ZK</given-names>
</name>
<name>
<surname>Wijeyesinghe</surname> <given-names>S</given-names>
</name>
<name>
<surname>Chandra</surname> <given-names>A</given-names>
</name>
<name>
<surname>Clauder</surname> <given-names>AK</given-names>
</name>
<etal/>
</person-group>. <article-title>Tissue-resident B cells orchestrate macrophage polarisation and function</article-title>. <source>Nat Commun</source>. (<year>2023</year>) <volume>14</volume>:<fpage>7081</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-023-42625-4</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>A</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>D</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>B cell-derived IL-10 promotes the resolution of lipopolysaccharide-induced acute lung injury</article-title>. <source>Cell Death Dis</source>. (<year>2023</year>) <volume>14</volume>:<fpage>418</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41419-023-05954-2</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murray</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Onufryk</surname> <given-names>C</given-names>
</name>
<name>
<surname>Tepper</surname> <given-names>RI</given-names>
</name>
<name>
<surname>Young</surname> <given-names>RA</given-names>
</name>
</person-group>. <article-title>T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection</article-title>. <source>J Immunol</source>. (<year>1997</year>) <volume>158</volume>:<page-range>315&#x2013;21</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.158.1.315</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schreiber</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ehlers</surname> <given-names>S</given-names>
</name>
<name>
<surname>Heitmann</surname> <given-names>L</given-names>
</name>
<name>
<surname>Rausch</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mages</surname> <given-names>J</given-names>
</name>
<name>
<surname>Murray</surname> <given-names>PJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity</article-title>. <source>J Immunol</source>. (<year>2009</year>) <volume>183</volume>:<page-range>1301&#x2013;12</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.0803567</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ring</surname> <given-names>S</given-names>
</name>
<name>
<surname>Eggers</surname> <given-names>L</given-names>
</name>
<name>
<surname>Behrends</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wutkowski</surname> <given-names>A</given-names>
</name>
<name>
<surname>Schwudke</surname> <given-names>D</given-names>
</name>
<name>
<surname>Kroger</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Blocking IL-10 receptor signaling ameliorates Mycobacterium tuberculosis infection during influenza-induced exacerbation</article-title>. <source>JCI Insight</source>. (<year>2019</year>) <volume>5</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/jci.insight.126533</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>R</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>A GPR174-CCL21 module imparts sexual dimorphism to humoral immunity</article-title>. <source>Nature</source>. (<year>2020</year>) <volume>577</volume>:<page-range>416&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41586-019-1873-0</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kulkarni</surname> <given-names>U</given-names>
</name>
<name>
<surname>Karsten</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Kohler</surname> <given-names>T</given-names>
</name>
<name>
<surname>Hammerschmidt</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bommert</surname> <given-names>K</given-names>
</name>
<name>
<surname>Tiburzy</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-10 mediates plasmacytosis-associated immunodeficiency by inhibiting complement-mediated neutrophil migration</article-title>. <source>J Allergy Clin Immunol</source>. (<year>2016</year>) <volume>137</volume>:<fpage>1487</fpage>&#x2013;<lpage>97 e6</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jaci.2015.10.018</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>